Please login to the form below

Not currently logged in
Email:
Password:

inflammatory diseases

This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.

Celgene bulks up pipeline again with $2.1bn Prothena deal

Celgene bulks up pipeline again with $2.1bn Prothena deal

Its latest deal gives it a preclinical-stage collaboration focused on targets with potential in neurodegenerative diseases including Alzheimer’s. ... smaller $101m collaboration with Vividion Therapeutics that also covers cancer and inflammatory

Latest news

  • Long-serving R&D head Bischofberger to leave Gilead Long-serving R&D head Bischofberger to leave Gilead

    depth of understanding of and caring for the needs of people living with those diseases, ”said Gilead’s chief executive John Milligan. ... diseases, inflammatory diseases and - perhaps most notably - cell-based cancer immunotherapy spearheaded by its

  • Lilly drops Hanmi-partnered arthritis drug Lilly drops Hanmi-partnered arthritis drug

    Merck KGaA is among the front-runners among companies developing BTK inhibitors for inflammatory diseases, with its evobrutinib progressing to phase IIb testing in rheumatoid arthritis last September, while Bristol-Myers ... Celgene was developing a BTK

  • Shaky mid-stage data won’t halt Celgene’s plans for Otezla Shaky mid-stage data won’t halt Celgene’s plans for Otezla

    Celgene intends to expand its use into a series of other inflammatory diseases with ulcerative colitis at the head of its list along with Behçet’s disease. ... Celgene reported stronger data with Otezla in reducing oral ulcers in patients with

  • Novartis joins biosimilar Humira push in US Novartis joins biosimilar Humira push in US

    Sandoz has already filed its Humira biosimilar in the EU, seeking approval as a cheaper alternative to AbbVie's drug in several immunological diseases, including psoriasis, rheumatoid arthritis and inflammatory bowel ... who suffer from an inflammatory

  • Takeda offers €520m for stem cell firm TiGenix Takeda offers €520m for stem cell firm TiGenix

    Takeda is already a player in inflammatory bowel diseases with its Entyvio (vedolizumab) product for ulcerative colitis and Crohn’s disease, one of its key growth products.

More from news
Approximately 2 fully matching, plus 112 partially matching documents found.

Latest Intelligence

  • The tipping point The tipping point

    In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.

  • Taking a lean and careful approach Taking a lean and careful approach

    Its fully human engineered CD3 antibody Foralumab has reached phase II with potential for a wide range of autoimmune and inflammatory diseases such as non-alcoholic steatohepatitis (NASH), primary biliary cholangitis, ... Database of diseases. The

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    It is a good fit strategically for us because it enriches our portfolio in the area of inflammatory and pain-related diseases with high unmet need. ... Pain has nervous and inflammatory components and we are interested in everything around the

  • Deal Watch December 2016 Deal Watch December 2016

    510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... The Scandinavian company, Nuevolution, uses its drug discovery platform Chemetics to discover novel small

  • Deal Watch October 2015 Deal Watch October 2015

    autoimmune and inflammatory diseases and allergy. ... 1, 000 ‡. Adheron Therapeutics/ Roche. Lead asset SDP051 mAb against Cadherin-11 in RA, fibrotic diseases (p1 complete).

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Infographic: Spondyloarthritis

    Infographic: Spondyloarthritis. Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics